Pages that link to "Q43873792"

The following pages link to Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. (Q43873792):

Displaying 50 items.

• Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents (Q24613945) (← links)
• Cannabis and psychosis/schizophrenia: human studies (Q24628837) (← links)
• Gone to Pot - A Review of the Association between Cannabis and Psychosis (Q26865311) (← links)
• Cannabinoids and psychosis (Q28241328) (← links)
• International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂ (Q28298445) (← links)
• Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice (Q28469322) (← links)
• Stress regulates endocannabinoid-CB1 receptor signaling (Q30402136) (← links)
• Altering endocannabinoid neurotransmission at critical developmental ages: impact on rodent emotionality and cognitive performance. (Q30471167) (← links)
• Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens (Q30499463) (← links)
• Endocannabinoid signaling in the etiology and treatment of major depressive illness (Q30687668) (← links)
• CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health (Q33293362) (← links)
• Endocannabinoids and striatal function: implications for addiction-related behaviours (Q33583792) (← links)
• In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability (Q33751118) (← links)
• Endocannabinoids in the dentate gyrus (Q33757950) (← links)
• Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice (Q33804240) (← links)
• Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans (Q33886277) (← links)
• Comorbid mood, psychosis, and marijuana abuse disorders: a theoretical review (Q34067376) (← links)
• The endocannabinoid system as a target for the treatment of neurodegenerative disease (Q34098196) (← links)
• Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling. (Q34311721) (← links)
• The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings (Q34347558) (← links)
• The endocannabinoid system as a target for the treatment of visceral obesity and metabolic syndrome (Q34587990) (← links)
• The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use. (Q34626755) (← links)
• Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example. (Q35035828) (← links)
• Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex (Q35047001) (← links)
• Components of the endocannabinoid and dopamine systems are dysregulated in Huntington's disease: analysis of publicly available microarray datasets (Q35049600) (← links)
• The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors (Q35167301) (← links)
• The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis (Q35169067) (← links)
• The neurobiology and control of anxious states (Q35202929) (← links)
• Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2. (Q35626928) (← links)
• A novel subpopulation of 5-HT type 3A receptor subunit immunoreactive interneurons in the rat basolateral amygdala (Q35689548) (← links)
• Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology (Q35693323) (← links)
• The cannabinoid agonist WIN55212-2 decreases L-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats (Q35740152) (← links)
• Neurobiological Interactions Between Stress and the Endocannabinoid System. (Q36366731) (← links)
• The anti-nausea effects of CB1 agonists are mediated by an action at the visceral insular cortex (Q36382982) (← links)
• Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortex (Q36421863) (← links)
• Cannabinoid-1 receptor: a novel target for the treatment of neuropsychiatric disorders (Q36425951) (← links)
• Striatal D(2)/D(3) receptor availability is inversely correlated with cannabis consumption in chronic marijuana users. (Q36496045) (← links)
• Cannabinoid CB1 receptors are expressed by parietal cells of the human gastric mucosa (Q36572905) (← links)
• Acute effects of THC on time perception in frequent and infrequent cannabis users (Q36636653) (← links)
• Hippocampal interneurons co-express transcripts encoding the alpha7 nicotinic receptor subunit and the cannabinoid receptor 1 (Q36952150) (← links)
• Striatal CB1 and D2 receptors regulate expression of each other, CRIP1A and δ opioid systems (Q36972027) (← links)
• Gene expression of opioid and dopamine systems in mouse striatum: effects of CB1 receptors, age and sex. (Q37003653) (← links)
• Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in rats (Q37015433) (← links)
• Central and peripheral neuroendocrine peptides and signalling in appetite regulation: considerations for obesity pharmacotherapy (Q37079243) (← links)
• Putative Epigenetic Involvement of the Endocannabinoid System in Anxiety- and Depression-Related Behaviors Caused by Nicotine as a Stressor (Q37088001) (← links)
• Emerging strategies for exploiting cannabinoid receptor agonists as medicines (Q37230665) (← links)
• Review paper: Current strategies in the development of anti-obesity drugs and their safety concerns (Q37359377) (← links)
• Endocannabinoid-mediated control of synaptic transmission (Q37363621) (← links)
• The endogenous cannabinoid system protects against colonic inflammation (Q37370275) (← links)
• Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists (Q37387204) (← links)